Stocks and InvestingStocks and Investing
Tue, November 22, 2022
Mon, November 21, 2022
Fri, November 18, 2022

Anupam Rama Maintained (BBIO) at Buy with Decreased Target to $19 on, Nov 18th, 2022


Published on 2024-10-28 00:16:21 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $20 to $19 on, Nov 18th, 2022.

Anupam has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $23 on, Wednesday, August 24th, 2022
  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $30 on, Tuesday, July 26th, 2022